SpyGlass Pharma, Inc. (SGP)
24.45
+0.58
(+2.42%)
USD |
NASDAQ |
Apr 14, 16:00
24.45
0.00 (0.00%)
After-Hours: 20:00
SpyGlass Pharma Shareholders Equity (Quarterly) : 105.70M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Select Medical Holdings Corp. | 1.706B |
| Champions Oncology, Inc. | 4.283M |
| KalVista Pharmaceuticals, Inc. | -2.711M |
| Akari Therapeutics Plc | 28.33M |
| Intellia Therapeutics, Inc. | 671.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 116.33M |
| Total Liabilities (Quarterly) | 10.63M |
| Debt to Equity Ratio | 0.015 |
| Current Ratio | 12.67 |